[1] Chen L, Kang Z, Shen J, et al. An emerging antibacterial nanovaccine for enhanced chemotherapy by selectively eliminating tumor-colonizing bacteria[J]. Science Bulletin, 2024. (IF 18.8)
[2] Chen Y, Feng X, Wu Z, et al. USP9X-mediated REV1 deubiquitination promotes lung cancer radioresistance via the action of REV1 as a Rad18 molecular scaffold for cystathionine γ-lyase[J]. Journal of Biomedical Science, 2024, 31(1): 55. (IF 11.0)